-0.7%
BKR vs MRNA
+909.7%
-910.4%
-33.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -7.4% | -6.5% | -0.8% | -7.3% |
| 7D | -15.2% | +8.4% | -23.6% | -15.3% |
| 30D | -19.1% | +28.8% | -47.9% | -19.2% |
| 3M | -24.8% | +329.2% | -354.0% | -25.4% |
| 6M | -31.6% | +416.9% | -448.5% | -33.9% |
| YTD | +2.5% | +718.8% | -716.2% | -5.3% |
| 1Y | -0.7% | +924.9% | -925.6% | -9.3% |
| All | -0.7% | +909.7% | -910.4% | -9.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling